Movement Alert｜WuXi XDC Falls 3.18% in Regular Trading, US DoD 1260H List and Persistent Selling Pressure Weigh on WuXi Group

Market Focus10:13

On June 10, WuXi XDC fell 3.18% in regular trading, trading at 44.54 HKD/share, with trading volume of 61.28 million HKD. The stock has now dropped over 22% below the company's earlier buyback average price of 57.3 HKD.

On the news front, the US Department of Defense updated its Section 1260H list on June 8, adding 188 entities including WuXi AppTec, the affiliate of WuXi XDC's parent company WuXi Biologics. While the list does not directly freeze assets or ban securities trading, it raises compliance screening risks among banks, carriers, and clients, and may lead to cross-referencing with other restrictive lists. Meanwhile, despite intensive buybacks totaling approximately 500 million USD across the WuXi group — including 327 million HKD spent repurchasing 5.702 million shares at an average of 57.3 HKD — selling pressure remains unabated. Today, the broader WuXi ecosystem continued to weaken, with WuXi Biologics down 2.81%, GenScript Biotech down 2.86%, and Pharmaron down 3.23%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137170071?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 10:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137170071","market":"hk","top_or_hot":-1,"title":"Movement Alert｜WuXi XDC Falls 3.18% in Regular Trading, US DoD 1260H List and Persistent Selling Pressure Weigh on WuXi Group","media":"Market Focus","content":"<p><p>On June 10, WuXi XDC fell 3.18% in regular trading, trading at 44.54 HKD/share, with trading volume of 61.28 million HKD. The stock has now dropped over 22% below the company's earlier buyback average price of 57.3 HKD.</p><p>On the news front, the US Department of Defense updated its Section 1260H list on June 8, adding 188 entities including WuXi AppTec, the affiliate of WuXi XDC's parent company WuXi Biologics. While the list does not directly freeze assets or ban securities trading, it raises compliance screening risks among banks, carriers, and clients, and may lead to cross-referencing with other restrictive lists. Meanwhile, despite intensive buybacks totaling approximately 500 million USD across the WuXi group — including 327 million HKD spent repurchasing 5.702 million shares at an average of 57.3 HKD — selling pressure remains unabated. Today, the broader WuXi ecosystem continued to weaken, with WuXi Biologics down 2.81%, GenScript Biotech down 2.86%, and Pharmaron down 3.23%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi XDC Falls 3.18% in Regular Trading, US DoD 1260H List and Persistent Selling Pressure Weigh on WuXi Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi XDC Falls 3.18% in Regular Trading, US DoD 1260H List and Persistent Selling Pressure Weigh on WuXi Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-10 10:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 10, WuXi XDC fell 3.18% in regular trading, trading at 44.54 HKD/share, with trading volume of 61.28 million HKD. The stock has now dropped over 22% below the company's earlier buyback average price of 57.3 HKD.</p><p>On the news front, the US Department of Defense updated its Section 1260H list on June 8, adding 188 entities including WuXi AppTec, the affiliate of WuXi XDC's parent company WuXi Biologics. While the list does not directly freeze assets or ban securities trading, it raises compliance screening risks among banks, carriers, and clients, and may lead to cross-referencing with other restrictive lists. Meanwhile, despite intensive buybacks totaling approximately 500 million USD across the WuXi group — including 327 million HKD spent repurchasing 5.702 million shares at an average of 57.3 HKD — selling pressure remains unabated. Today, the broader WuXi ecosystem continued to weaken, with WuXi Biologics down 2.81%, GenScript Biotech down 2.86%, and Pharmaron down 3.23%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02268","symbol_name":"药明合联","start_time":0,"source_url":"","article_id":"1137170071","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137170071","pubTimestamp":1781057601,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 10, WuXi XDC fell 3.18% in regular trading, trading at 44.54 HKD/share, with trading volume of 61.28 million HKD. The stock has now dropped over 22% below the company's earlier buyback...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02268":"药明合联"},"translate_title":"动静提示|药明XDC常规交易跌3.18%，美国国防部1260H清单及持续抛压令药明集团承压","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"On June 10, WuXi XDC fell 3.18% in regular trading, trading at 44.54 HKD/share, with trading volume of 61.28 million HKD. The stock has now dropped over 22% below the company's earlier buyback average price of 57.3 HKD.On the news front, the US Department of Defense updated its Section 1260H list on June 8, adding 188 entities including WuXi AppTec, the affiliate of WuXi XDC's parent company WuXi Biologics. While the list does not directly freeze assets or ban securities trading, it raises compliance screening risks among banks, carriers, and clients, and may lead to cross-referencing with other restrictive lists. Meanwhile, despite intensive buybacks totaling approximately 500 million USD across the WuXi group — including 327 million HKD spent repurchasing 5.702 million shares at an average of 57.3 HKD — selling pressure remains unabated. Today, the broader WuXi ecosystem continued to weaken, with WuXi Biologics down 2.81%, GenScript Biotech down 2.86%, and Pharmaron down 3.23%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137170071","isCrawlerRequest":true}